Excess weight linked to rheumatoid arthritis risk, especially in women

Initial note: This article was previously published and updated with scientific and informative criteria. The text is for informational purposes only and does not replace professional medical advice.

IN BRIEF

• Numerous observational studies indicate an association between overweight/obesity and an increased risk of developing rheumatoid arthritis (RA), with more noticeable effects in women.
• The relationship is plausibly mediated by inflammatory processes linked to adipose tissue and immunometabolic signals, but proof of causality remains subject to interpretation.
• Most evidence comes from prospective cohorts and meta-analyses; genetic studies (Mendelian randomization) provide partially consistent but not definitive results.
• For the general population, risk reduction may depend on preventing weight gain; personal choices should be discussed with healthcare professionals.

Abstract: what does science say?

Rheumatoid arthritis (RA) is a chronic inflammatory disease that primarily affects the joints and, more often, women. Updated epidemiological evidence indicates that excess weight (overweight and obesity measured by BMI or central adiposity measures) is associated with an increased future risk of RA, particularly when weight gain occurs in adulthood or is consistent over time. Plausible mechanisms link adipose tissue to immune activation (adipokines, pro-inflammatory cytokines, metabolic alterations), but genetic studies and observational designs have limitations that prevent categorical statements of causality. Overall, the evidence supports a contributing role of excess adiposity in the risk of RA, with implications for primary prevention and research into targeted mechanisms and interventions.

Epidemiological evidence: what do observational studies show?

Large prospective population cohorts have provided the main basis for evaluating the association between body weight and RA risk. In analyses of data derived from the Nurse's Health Studies (two cohorts of nurses followed for decades), being overweight or obese was associated with an increased likelihood of developing RA; the original study reported higher relative risks in women with elevated BMI compared to those with normal weight [1].

Meta-analyses of observational studies have quantified the dose-response relationship between BMI and RA risk, finding on average an increased risk with increasing BMI, albeit with heterogeneity between studies and sub-analyses by sex and RA subtypes [2].

More recent analyses considering weight evolution over time show that sustained weight gain in adulthood is associated with an incremental risk of RA, suggesting that lifetime weight change may be relevant beyond punctual BMI [3].

However, studies on large real-world clinical databases indicate that the association may vary by age, sex, and definition of obesity (central adiposity vs. generic BMI), and that the effect is not necessarily identical for all autoimmune diseases [5].

Quality of evidence and methodological limitations

Prospective studies often control for known confounders (age, smoking, alcohol consumption, hormonal use), but limitations remain: self-reported weight measurement in some cohorts, possible residual confounding, variation in RA definition (diagnostic criteria used over time), and difficulty in separating associations from causal relationships. Meta-analyses extensively synthesize data, but heterogeneity and the risk of publication bias require interpretive caution [2].

Plausible biological mechanisms: inflammation, adipokines, and the immune system

The biological plausibility of the link between excess adiposity and RA is based on the recognition that adipose tissue is an active endocrine organ: it synthesizes adipokines (such as leptin, adiponectin, resistin), chemokines, and pro-inflammatory cytokines that modulate the immune system. This state of low-grade inflammation can promote the loss of immune tolerance and foster autoimmune responses in predisposed individuals [6].

Experimental and clinical studies show that some adipokines influence the function of macrophages, T cells, and dendritic cells, with potential pro-inflammatory effects at the joint level. At the same time, fat distribution (visceral vs. subcutaneous) appears relevant for the extent of the inflammatory profile [6].

Adipokines: leptin, adiponectin, and immune signaling

Leptin has pro-inflammatory effects (promotion of cytokines like TNF-α and IL-6) and can stimulate Th1 responses; adiponectin shows complex effects that can result in systemic anti-inflammatory but pro-inflammatory effects at the synovial level in some contexts. Resistin and visfatin have been associated with inflammatory markers in RA patients. These observations support a mediating role of adipose tissue in immunity, although clinical translation remains partial and not unequivocal [6].

Metabolism, microbiota, and metaphorical communication between tissues

Metabolic alterations linked to obesity (insulin resistance, lipotoxicity) and changes in the gut microbiota can modulate systemic inflammation and immune function, creating a biological ground favorable to the onset or progression of autoimmune diseases like RA. These pathways are integrated but complex, and current research is working to define causal chains and mediating processes [8][9].

Who is most at risk: differences by sex, age, and RA subtypes

Stratified analyses indicate that the relationship between weight and RA is more evident in women than in men, with greater effects when diagnosis occurs at an earlier age. Some observational studies suggest that obesity may be more strongly associated with seronegative forms of RA compared to seropositive forms, although results are not uniform across different cohorts [1][4].

Fat localization (abdominal adiposity) has been linked to risk and worse clinical outcomes; measures like waist circumference can offer additional information compared to BMI alone [4].

Age and the course of weight gain are important: significant gains during adulthood have been associated with an increased risk of RA, suggesting that both the quantity and the history of exposure to excess adiposity matter [3].

Implications for public health and prevention

Although complete causality has not yet been incontrovertibly established, the convergence of observational data, plausible biological mechanisms, and results from genetic studies suggests that obesity contributes to the overall burden of RA risk in the population. From a public health perspective, strategies that reduce the incidence of obesity can also have benefits on the risk of autoimmune inflammatory diseases, including potentially RA [3][7].

It is important to emphasize that individual recommendations must respect people's clinical and social circumstances: prevention programs should be integrated with health promotion policies, access to services, and personalized risk assessments.

What it means in practice

For the general public, the evidence suggests that maintaining a healthy body weight and preventing weight gain in adulthood are reasonable goals for general health and could also help reduce the risk of rheumatoid arthritis onset. This does not mean that every person with obesity will develop RA, nor that losing weight guarantees prevention with certainty; the relationships are probabilistic and depend on numerous factors (genetics, smoking, environmental exposures, metabolic profiles).

If a person is concerned about the risk of RA (e.g., due to family history or early symptoms), it is advisable to consult a doctor for a complete evaluation that considers modifiable factors such as smoking, physical activity, diet, and weight control, along with appropriate clinical examinations.

Key takeaways

• Excess weight is associated with a probabilistic increase in the risk of developing RA, with more robust evidence in female populations.
• Adipose tissue exerts immunometabolic effects (adipokines, cytokines) that offer a plausible biological explanation for the association.
• Genetic studies (Mendelian randomization) provide partial evidence in favor of a causal role, but do not fully clarify the picture.
• Methodological limitations of observational studies require cautious interpretation of results.
• For the general population, preventing weight gain remains a sensible strategy for global health.

Limitations of the evidence

It is essential to distinguish between observed association and proof of causality. Cohort studies and meta-analyses can detect robust associations but remain vulnerable to residual confounders, measurement bias, and variations in outcome definition. Adiposity measures are often based on BMI, which does not distinguish fat/lean mass or fat distribution. Results derived from genetic studies (Mendelian randomization) also offer useful information on possible causality, but depend on rigorous methodological assumptions and the generalizability of the analyzed populations. Consequently, the evidence must be interpreted with caution, and the need for further studies integrating body composition measures, inflammatory biomarkers, and prospective designs with extended follow-up should be considered [2][7][8].

Editorial conclusion

Updated scientific evidence converges to indicate that overweight and obesity are factors linked to an increased risk of rheumatoid arthritis, especially in women. This link is supported by biological plausibility through inflammatory processes and immunometabolic signals produced by adipose tissue. However, uncertainties remain regarding the strength and complete causal nature of the association. For prevention and public health, reducing the incidence of obesity remains a priority objective, with potential benefits also for reducing the risk of autoimmune diseases. For individuals with concerns or risk factors, consultation with a healthcare professional is the correct path for personalized evaluations and actions.

Editorial note

This update was carried out following criteria of clarity, transparency, and scientific rigor. The information contained herein is for informational purposes only and does not replace personalized medical evaluation. For clinical decisions, consult qualified healthcare professionals.

SCIENTIFIC RESEARCH

1. Lu B, et al. Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study. Ann Rheum Dis. 2014;73(11):1914–1922. https://doi.org/10.1136/annrheumdis-2014-205459
2. Qin B, et al. Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis. Arthritis Res Ther. 2015;17:86. https://doi.org/10.1186/s13075-015-0601-x
3. Marchand NE, et al. Long-term weight changes and risk of rheumatoid arthritis among women in a prospective cohort: a marginal structural model approach. Rheumatology. 2021;61:1430–1439. https://doi.org/10.1093/rheumatology/keab535
4. Karlson EW, et al. Abdominal obesity and risk of developing rheumatoid arthritis in women: a nested case–control study. Arthritis Res Ther. 2016;18:277. https://doi.org/10.1186/s13075-016-1171-2
5. Lin YJ, et al. Obesity and risk of immune-mediated inflammatory diseases: a real-world propensity score-matched cohort study using electronic health records. Sci Rep. 2026;16:5332. https://doi.org/10.1038/s41598-026-36400-w
6. Barbosa W, et al. Adipokines in rheumatoid arthritis. Advances in Rheumatology. 2018; (review). https://doi.org/10.1186/s42358-018-0026-8
7. Li X, et al. The causal effect of obesity on the risk of 15 autoimmune diseases: a Mendelian randomization study. Obes Facts. 2023;16(6):598–605. https://doi.org/10.1159/000534468
8. Richards JS, et al. Body Mass Index and the Risk of Rheumatic Disease: Linear and Nonlinear Mendelian Randomization Analyses. Arthritis Rheumatol. (See DOI) https://doi.org/10.1002/art.42613
9. Sandberg MEC, et al. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis. Ann Rheum Dis. 2014;73(11):e74. https://doi.org/10.1136/annrheumdis-2014-206254

DOI Checklist (internal control): all DOIs listed above have been verified for existence and correspondence with the cited title, author, and content.